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Progress in Biochemical Pharmacology.
Vol. 11. Biological Basis of Clinical
Effect of Bleomycin. Ed. A. CAPUTO
(1976) Basel, Miinchen, Paris, London, New
York, Sydney: S. Karger. 230 pp. 74
Figs. 69 Tables. $49.00 net.
This book is a collection of papers in the
Progress in Biochemical Pharmacology series,
and is concerned, withh both experimental and
clinical aspects of the antitumour agent
bleomycin (BLM), written by many dis-
tinguished authorities in the field. The book
is of considerable value to both experi-
mentalist and clinician engaged in general
antitumour chemotherapy. The editor is to
be commended on the content and layout of
the publication, which contains very useful
and readable reviews, especially on the basic
experimental evidence, leading to its clinical
use. Appropriately, the structure and action
of BLM is surveyed by H. Umezawa, -who
discusses both the complex chemistry of the
agent and the initial biological effects wNhich
led to its selection as a potentially valuable
agent. Throughout the book, detailed factual
data on dosage and biological action are
given -without distracting from the read-
ability ofthe text. W. E. G. Muller and R. K.
Zahn discuss the important detailed studies
of BLM on DNA, RNA aind protein bio-
chemistry, -with a section on its action on
growth of oncogenic RNA viruses and on cell
transformation. A more detailed study is
given by Tetsuo Ono and co-workers on the
action of BLM on DNA ligase and poly-
merases, outliniiXg the evidence w-hich shows
that only one of the 4 DNA polymerases in
spleen is inhibited by the drug, together with
the special DNA polymerase associated -with
oncogenic RNA virus activity. H. Endo
discusses the mechanism of BLM sensitivity
in E. coli and the implication of these
findings to cancer chemotherapy. In par-
ticular, he outlines the properties of BLM-
sensitive mutants obtained by MNNG muta-
genization. T. Terasima and co-workers
review the mammalian cell-survival data in
relation to tumour therapy, and S. C.
Barranco and R. M. Humphrey the response
of cells to the potentially lethal and sublethal
damnage by the drug. Plateau-phase
cultures are especially considered by F.
Mauro and co-wNorkers. Other aspects of
BLM treatment, such as growth changes in
hairless mouse epidermis (0. H. Iversen,
et al.) and the presence of BLM-inactivating
enzyme systems (W. E. G. Muller and R. F.
Zahln) are also discussed in some detail,
together with useful data on the systems
used, so that application to other drug studies
could be undertaken from the information
given. An interesting verbatim account of
a general discussion between these authors
on the experimental aspects completes this
section of the book.
The steps in the discovery of the clinical
effectiveness of the drug is then recalled in a
highly readable discourse by T. Ichikawa,
who, writh his colleagues, initiated these
studies. An anecdotal account of the
rationale for the choice of this agent in a
patient with penile cancer, the circum-
stances leading to its choice and the resultant
dramatic effect makes interesting reading.
S. K. Carter and R. H. Blum bring together
the subsequent international clinical experi-
ence wN-ith the drug, albeit largely in terminal
patients as a single drug treatment. With
a number of provisos, the agent may be
expected to provide benefit to patients with
lymphoma, testicular tumours and squamous-
cell carcinomas in certain anatomical sites.
However, its greatest potential would appear
to be in combination with otlher agents, and
this aspect is enlarged upon by A. Barduagni
and co-w-orkers, and for malignant melano-
mas and testicular tumours by E. Folke et al.
Lung toxicity appears to be a problem (G.
Bonadonna et al.) but nevertheless, its roles
in the treatment of metastatic cancer as well
as in head and neck tumours (A. Depierre),
laryngeal tumours recurring after radio-
therapy (J. Rygard and A. S. Hansen) and
malignant tumours of the male genitalia (P.
Rathert and W. Lutzeyer) may be important
ones.
The book is highly recommended to both
experimentalists and clinicians alike, and
fully justifies Dr Caputo's opening comments
that the agent "has stimulated the interest
in many fields ofresearch and application and292 1300K REVIEWS
presently represents one of the most suitable
models for an interdisciplinary attack on
cancer".
B. W. Fox
Histological Typing of Intestinal
Tumours. B. C. MORSON. (1976)
Geneva: WHO. 69 pp. 134 colour photo-
graphs. Sw,.Fr. 80; US $32. The photo-
graphs are also available as a set of colour
transparencies, price (complete with book)
Sw.Fr. 215; US $86.
This is Vol. 15 of the WHO International
Histological Classification of Tumours. These
volumes have appeared over the past 10
years, and enough have now been published
for the quality and scope of the project to be
apparent. These are not textbooks or mono-
graphs; their aim is to promote an inter-
nationally agreed terminology and classifica-
tion of human tumour types. Essentially
they are collections of colour photomicro-
graphs of sections, stained by conventional
methods, with a scheme of classification and
brief explanatory notes. The importance of
achieving an agreed nomenclature for epide-
miological purposes or for organizing clinical
trials is obvious. These volumes are also of
great value to diagnostic histopathologists,
specially to those without ready access to
specialized reference laboratories. Armed
with these volumes, and the U.S. Armed
Forces Institute ofPathology's Atlas ofTumor
Pathology, the histopathologist should be able
to cope effectively with most ofthe diagnostic
problems presented by human neoplasia.
Both sets are essential items for the diagnostic
laboratory.
This volume on intestinal tumours comes
from St Mark's Hospital, London, and has
all the merits one expects from that renowned
centre. This is, in fact, one of the best ofthe
volumes so far in this series. The regions
covered are the small intestine, appendix,
large intestine, anal canal and anal margin.
As well as tumours, valuable sections are
devoted to the tumour-like lesions, so often
a source of diagnostic difficulty in these
regions. Not everyone will agree with the
details of the classification adopted, but
pathologists should be encouraged to give it a
trial. The explanatory notes are brief and
pithy. The microphotographs are all of
excellent quality and superbly reproduced.
The endocrinle tumours of the intestinal tract
(a fascinating newr chapter in pathology) are
only incidentally mentioned-but a full
treatment is promised in the forthcoming
volume on endocrine tumours. In summary,
an excellently produced, authoritative and
invaluable atlas of intestinal tumours. (In
the review copy Figs. 121-134 appear twice
over, first bound upside dowAn between Figs.
96 and 97, and then in their right place.)
0. G. DODGE
Fundamental and Clinical Studies of
Bleomycin. GANN Monograph on
Cancer Research No. 19, Japanese Cancer
Association. Eds. S. K. CARTER, T.
ICHIKAWA, G. MATHE and H. UMEZAWA.
(1976). London: University Park Press.
320 pp. £31.95 net.
Bleomycin (BLM), an anticancer anti-
biotic was discovered in Japan by Umezawa
and his colleagues in 1959 and has been the
subject of much experimental and clinical
research since that time. It is appropriate
therefore that this monograph should be
published on behalf of the Japaneze Cancer
Association to summarise the data. Un-
fortunately, as is usual in such books, it is
already partially out of date, but it still
remains the best on the subject.
The first 96 pages, devoted to fundamental
aspects, are the most consistently good.
These contain an excellent introduction by
Umezawa on the history, chemistry and
action of the drug. Its pattern of binding
and reaction with DNA and the variable
inactivation of the drug in different tissues
and tumours go a long wxNay to explain some
of its unique features, in particular its action
on squamous-cell tissue and tumours. Two
other chapters in the section by Japanese
and German wrorkers amplify some aspects
of this problem.
The remaining part of the section on
fundamental aspects is concerned with its
action in terms of cell kinetics. Terasima
and Barranco with their colleagues provide
twro useful but slightly outdated chapters in
which features of repair, phase specificity,
resistance and use as a synchronizing agent
are discussed.
The remainder of the book is devoted to
clinical subjects. The most noticeable of
these is the excellent review by Shanta and